Boston Scientific Corporation
MX ˙ BMV ˙ FR0010424135
SecurityMX:BSX / Boston Scientific Corporation
InstitutionUniSuper Management Pty Ltd
Latest Disclosed Ownership719,670 shares
Latest Disclosed Value $ 45,159,292
UniSuper Management Pty Ltd reports 5.39% decrease in ownership of BSX / Boston Scientific Corporation

On May 11, 2026 - UniSuper Management Pty Ltd filed a 13F-HR form disclosing ownership of 719,670 shares of Boston Scientific Corporation (MX:BSX) valued at $45,159,292 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 760,684 shares of Boston Scientific Corporation. This represents a change in shares of -5.39% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F BOSTON SCIENTIFIC COM 101137107 719,670 -41,014 -5.39 45,159 -37.74 0.2954
2026-02-12 2025-12-31 13F BOSTON SCIENTIFIC COM 101137107 760,684 -318,658 -29.52 72,531 -31.17 0.4345
2025-10-31 2025-09-30 13F BOSTON SCIENTIFIC COM 101137107 1,079,342 169,181 18.59 105,376 7.79 0.6451
2025-07-22 2025-06-30 13F BOSTON SCIENTIFIC COM 101137107 910,161 -67,930 -6.95 97,760 -0.92 0.6552
2025-05-15 2025-03-31 13F BOSTON SCIENTIFIC COM 101137107 978,091 2,130 0.22 98,670 13.19 0.7354
2025-02-12 2024-12-31 13F BOSTON SCIENTIFIC COM 101137107 975,961 550,439 129.36 87,173 144.47 0.6254
2024-11-14 2024-09-30 13F BOSTON SCIENTIFIC COM 101137107 425,522 355,303 505.99 35,659 559.48 0.2682
2024-08-05 2024-06-30 13F BOSTON SCIENTIFIC COM 101137107 70,219 36,487 108.17 5,408 134.07 0.0449
2024-05-13 2024-03-31 13F BOSTON SCIENTIFIC COM 101137107 33,732 21,623 178.57 2,310 230.00 0.0221
2024-02-13 2023-12-31 13F BOSTON SCIENTIFIC COM 101137107 12,109 -9,855 -44.87 700 -39.60 0.0077
2023-11-13 2023-09-30 13F BOSTON SCIENTIFIC COM 101137107 21,964 -2,308 -9.51 1,160 -11.66 0.0142
2023-11-13 2023-06-30 13F/A-1 BOSTON SCIENTIFIC COM 101137107 24,272 24,272 1,313 0.0149
2023-08-14 2023-06-30 13F BOSTON SCIENTIFIC COM 101137107 493,242 493,242 26,679 0.2164
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.